Journal of the European Academy of Dermatology and Venereology,
Journal Year:
2024,
Volume and Issue:
38(2), P. 245 - 246
Published: Jan. 24, 2024
In
recent
years,
our
understanding
of
the
disease
burden
in
atopic
dermatitis
(AD)
has
been
increasing,
and
we
have
seen
a
wide
range
studies
concentrating
on
clinical,
psychological
economic
aspects
disease.
AD
is
one
most
frequent
chronic
skin
conditions,
thus,
concepts
its
are
relevant
to
every
doctor,
especially
dermatologists.
The
work
Eyerich
et
al.1
major
addition
this
continuum
research
contains
three
specific
strengths.
First,
well-conducted
extensive
study
comprises
validated
real-life
data,
which
many
previous
publications
lacked.
Second,
there
interesting
subgroup
analyses
open
discussions
about
causes
asymmetrically
distributed
subsequently,
targeted
therapies.
addition,
third,
was
conducted
multiple
countries,
enables
systematic
analysis
relatively
heterogenous
populations.
An
old
medical
saying
states
that
not
be
equated
with
burden.2
Every
patient,
whatever
origin,
background
or
severity,
his
her
own
illness,
comprising
all
the,
mentioned,
key
components
but
limited
them.
As
different
countries
populations
may
differ,
important
question
what
as
dermatologists
can
do
lower
it
effectively,
considering
perpetual
boundaries,
economics
resources.3,
4
past
new
medicaments
introduced
armamentarium
treatments
several
more
waiting
follow.5
authors
could
show
patients
receiving
systemic
medications
had
significantly
burden,
gives
hope
for
future.
However,
they
also
observed
still
exists
substantial
moderate-to-severe
AD.6
What
main
factors
each
individual
patient
contribute
burden?
burden-targeting?
How
you
manage
based
holistic
approaches?
These
kinds
questions
practising
dermatologist
regularly
ask
himself
herself.
But
nevertheless,
remains
condition
maybe
all,
measures
doctor's
skills,
view
causes.
al.
succeeded
make
significant
scientific
contribution
population-based
multinational
levels.
It
rests
clinical
put
these
observations
into
practice.
None
declare.
Data
sharing
applicable
article
no
datasets
were
generated
analysed
during
current
study.
Experimental Dermatology,
Journal Year:
2023,
Volume and Issue:
32(7), P. 975 - 985
Published: April 7, 2023
Abstract
Two
serious
health
conditions,
obesity
and
atopic
dermatitis
(AD),
share
some
pathological
features
such
as
insulin
resistance,
leptin
resistance
inflammation,
a
growing
body
of
evidence
suggests
link
between
AD.
Obesity
predisposes
an
individual
to
and/or
worsens
AD,
whereas
AD
increases
the
risk
obesity.
AD's
interactions
are
mediated
by
cytokines,
chemokines
immune
cells.
Obese
individuals
with
more
resistant
anti‐inflammatory
therapy,
while
weight
loss
can
alleviate
In
this
review,
we
summarize
linking
We
also
discuss
pathogenic
role
in
vice
versa.
Because
connection
these
two
mitigation
one
could
possibly
prevent
development
or
other
condition.
Effective
management
enhance
wellness
both
conditions.
However,
proper
clinical
studies
warranted
validate
speculation.
Immunological Reviews,
Journal Year:
2025,
Volume and Issue:
331(1)
Published: March 31, 2025
Type
2-mediated
immune
responses
protect
the
body
against
environmental
threats
at
barrier
surfaces,
such
as
large
parasites
and
toxins,
facilitate
repair
of
inflammatory
tissue
damage.
However,
maladaptive
to
typically
nonpathogenic
substances,
commonly
known
allergens,
can
lead
development
allergic
diseases.
2
immunity
involves
a
series
prototype
TH2
cytokines
(IL-4,
IL-5,
IL-13)
alarmins
(IL-33,
TSLP)
that
promote
generation
adaptive
CD4+
helper
cells
humoral
products
allergen-specific
IgE.
Mast
basophils
are
integral
players
in
this
network,
serving
primary
effectors
IgE-mediated
responses.
These
bind
IgE
via
high-affinity
receptors
(FcεRI)
expressed
on
their
surface
and,
upon
activation
by
release
variety
mediators
regulate
responses,
attract
modulate
other
cells,
contribute
repair.
Here,
we
review
biology
effector
mechanisms
these
focusing
primarily
role
mediating
both
physiological
pathological
contexts.
Journal of Allergy and Clinical Immunology,
Journal Year:
2024,
Volume and Issue:
153(4), P. 1155 - 1161.e4
Published: Jan. 23, 2024
Background:
Pathogenic
variants
in
filaggrin
(FLG)
are
associated
with
an
increased
risk
of
atopic
dermatitis
(AD).Objective:
To
evaluate
the
influence
FLG
on
effectiveness
dupilumab
treatment
AD.
Methods:This
prospective
observational
study
included
adult
AD
patients
treated
from
BioDay
Registry.FLG
was
analysed
smMIP
targeted
sequencing.Novel
mutations
were
confirmed
by
Sanger
sequencing.Eczema
Area
and
Severity
Index
(EASI),
Investigator
Global
Assessment
(IGA),
Numeric
Rating
Scale
(NRS)
pruritus,
Dermatology
Quality
Life
(DLQI)
Patient
Oriented
Eczema
Measure
(POEM)
assessed
at
baseline,
week
16
52.Results:
Genetic
analysis
285
showed
bi-allelic
pathogenic
(FLG-/-)
n=41
(14%),
mono-allelic
(FLG-/+)
n=64
(23%)
wild-type
alleles
(FLG+/+)
n=180
(63%).Three
novel
found.We
observed
no
clinically
relevant
differences
EASI,
IGA,
NRS
DLQI
total
POEM
scores
for
without
all
time
points.The
FLG-/-group
significantly
higher
flaking
dryness
(p<0.001and
p=0.002,
respectively)
52
(p<0.001
p=0.016,
compared
to
FLG+/+,
also
significant
FLG-/+,
while
delta
nonsignificant.
Conclusion:This
suggests
that
not
influenced
variants.However,
tended
have
a
drier
skin
before
during
or
alleles.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: July 15, 2024
Background
Atopic
dermatitis
(AD)
is
a
chronic
relapsing,
pruritic,
inflammatory
skin
disease.
Assessing
the
characteristics
and
risk
factors
of
severe
AD
central
to
healthcare
workers’
understanding
subsequent
education
patients
for
most
optimal
outcomes.
The
clinical
are
known
vary
depending
on
populations
regions.
has
been
well-documented
in
global
North
mainly
Caucasian
populations,
while
very
few
studies
have
conducted
African
residing
Africa.
This
study
assessed
characteristics,
severity,
sociodemographic
children
with
Southern
Ethiopia.
Methods
A
hospital-based
cross-sectional
was
among
461
their
caregivers
four
randomly
selected
hospitals
Ethiopia
from
October
2022
September
2023.
systematic
sampling
technique
used
enroll
participants.
Clinical
profile
data
were
collected
by
trained
collectors.
Scoring
Dermatitis
(SCORAD)
index
tool
used.
descriptive
analysis
performed
characterize
Univariate
ordinary
logistic
regression
identify
associated
SCORAD
score.
OR
95%
show
strength
association,
p-
value
<0.05
declare
level
significance.
Result
Out
AD-diagnosed
children,
212
(46%)
girls
249
(54%)
boys.
In
sample
pediatric
patients,
149
(32.3%)
exhibited
mild
AD,
231
(46.2%)
presented
moderate,
99
(21.5%)
showed
signs
symptoms
AD.
All
had
itching.
Dryness
skin,
excoriation,
erythema,
followed
lichenification,
observed
signs.
model,
age
onset
disease
[AOR
CI
1.95
(1.3–2.94)],
sex
caregiver
or
family
0.61
(0.41–0.90)],
atopy
history
0.64
(0.44–0.93)],
mother
status
[95%
2.45
(1.1–5.47)],
use
herbal
medication
0.50
(0.33–0.79)]
significantly
severity
Conclusion
this
study,
68%
found
moderate-to-severe
Early
onset,
maternal
education,
familial
history,
caregiver,
independent
predictors
children.
We
recommend
further
investigation
into
these
variables
potential
serve
as
markers
assess
improve
care
management
Postgraduate Medical Journal,
Journal Year:
2024,
Volume and Issue:
100(1187), P. 649 - 656
Published: April 2, 2024
Abstract
Background
The
pathogenesis
of
atopic
dermatitis
(AD)
remains
unclear.
Nontyphoidal
Salmonella
(NTS)
infection
might
trigger
immune-mediated
reactions.
We
aimed
to
examine
NTS
and
the
risk
subsequent
AD.
Methods
From
2002
2015,
eligible
patients
(aged
0–100
years)
with
were
identified.
non-NTS
groups
matched
at
a
1:10
ratio
on
age
sex.
utilized
conditional
multivariable
Cox
proportional
hazard
models
estimate
adjusted
(aHR)
95%
confidence
interval
(CI)
for
AD
development.
Subgroup
analyses
conducted
based
age,
sex,
severity
infection.
landmark
analysis
explore
time-dependent
following
NTS.
Results
In
group
(N
=
6624),
403
developed
After
full
adjustment
demographics
comorbidities,
had
higher
than
reference
(aHR
1.217,
CI
1.096–1.352).
Age-stratified
revealed
that
exhibited
an
elevated
compared
group,
particularly
among
those
aged
13–30
years
1.25,
1.017–1.559),
individuals
31–50
1.388,
1.112–1.733),
51–70
1.301,
1.008–1.679),
71
over
1.791,
1.260–2.545).
Severe
was
associated
2.411,
1.577–3.685).
Landmark
showed
generally
consistent
findings.
Conclusions
Minimizing
exposure
may
represent
prospective
strategy
averting
onset
progression
dermatitis.
Contact Dermatitis,
Journal Year:
2024,
Volume and Issue:
91(3), P. 203 - 211
Published: May 22, 2024
Abstract
Background
Earlier
studies
suggested
a
potential
association
between
tobacco
smoking
and
nickel
sensitization,
but
little
is
known
about
other
contact
allergens.
Objectives
To
investigate
the
of
status
sensitizations
as
well
subtypes
dermatitis,
to
analyse
sensitization
profiles
smokers.
Patients
Methods
Within
Information
Network
Departments
Dermatology
(IVDK),
we
performed
cross‐sectional
multicentre
pilot
study
comprising
1091
patch‐tested
patients
from
9
departments,
comparing
541
with
history
cigarette
(281
current
260
former
smokers)
550
never‐smokers.
Results
We
could
not
confirm
previously
reported
smoking.
Moreover,
allergens,
including
colophony,
fragrance
mix
I,
Myroxylon
pereirae
formaldehyde,
were
increased
in
smokers
compared
never
Hand
dermatitis
(50.6%
vs.
33.6%)
occupational
cause
(36.2%
22.5%)
significantly
more
frequent
among
never‐smokers
shown
by
non‐overlapping
95%
confidence
intervals.
Conclusions
Although
our
does
allow
firm
conclusion
on
whether
contributes
certain
sensitizations,
it
confirms
an
hand
cause.